- Home
- NXTT vs SCNI Comparison
NXTT vs SCNI Comparison
Compare NXTT & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTT
- SCNI
- Stock Information
- Founded
- NXTT 2019
- SCNI 2003
- Country
- NXTT China
- SCNI Israel
- Employees
- NXTT N/A
- SCNI N/A
- Industry
- NXTT
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXTT
- SCNI Health Care
- Exchange
- NXTT NYSE
- SCNI Nasdaq
- Market Cap
- NXTT 3.5M
- SCNI 2.8M
- IPO Year
- NXTT N/A
- SCNI N/A
- Fundamental
- Price
- NXTT $0.29
- SCNI $2.85
- Analyst Decision
- NXTT
- SCNI
- Analyst Count
- NXTT 0
- SCNI 0
- Target Price
- NXTT N/A
- SCNI N/A
- AVG Volume (30 Days)
- NXTT 363.4K
- SCNI 10.1K
- Earning Date
- NXTT 05-19-2025
- SCNI 05-14-2025
- Dividend Yield
- NXTT N/A
- SCNI N/A
- EPS Growth
- NXTT N/A
- SCNI N/A
- EPS
- NXTT 3.70
- SCNI 8.20
- Revenue
- NXTT $1,800,000.00
- SCNI $452,000.00
- Revenue This Year
- NXTT N/A
- SCNI N/A
- Revenue Next Year
- NXTT N/A
- SCNI N/A
- P/E Ratio
- NXTT $0.08
- SCNI $0.34
- Revenue Growth
- NXTT N/A
- SCNI N/A
- 52 Week Low
- NXTT $0.28
- SCNI $2.23
- 52 Week High
- NXTT $6.66
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- NXTT 27.15
- SCNI 34.84
- Support Level
- NXTT $0.28
- SCNI $2.64
- Resistance Level
- NXTT $0.32
- SCNI $2.86
- Average True Range (ATR)
- NXTT 0.03
- SCNI 0.25
- MACD
- NXTT 0.04
- SCNI -0.06
- Stochastic Oscillator
- NXTT 13.33
- SCNI 35.93
About NXTT NEXT TECHNOLOGY HOLDING INC
Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.